Environmental Chemical Exposure May Contribute to Uterine Cancer Development:Studies with Tetrabromobisphenol A

Toxicologic Pathology

Volumn 43, Issue 4, 2015, Pages 464-473

  Dunnick, J K ^a   Sanders, J M ^b   Kissling, G E ^a   Johnson, C L ^c   Boyle, M H ^d   Elmore, S A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CHARLES RIVER LABORATORIES   (United States)

^d INTEGRATED LABORATORY SYSTEMS   (United States)

Author keywords

flame retardants; malignant mixed M llerian tumors (MMMT); tetrabromobisphenol A; uterine tumors

Indexed keywords

CARCINOGEN; POLLUTANT; POLYBROMINATED BIPHENYL; TETRABROMOBISPHENOL A; ESTROGEN; FREE RADICAL; HYDROXYSTEROID DEHYDROGENASE; SULFOTRANSFERASE;

ANIMAL; BODY WEIGHT; CARCINOGEN TESTING; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; PATHOLOGY; POLLUTANT; TOXICITY; UTERUS; UTERUS CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL INFILTRATION; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ENDOMETRIUM TUMOR; ENVIRONMENTAL EXPOSURE; EPITHELIUM TUMOR; FORESTOMACH; GERM LAYER; IMMUNE RESPONSE; KIDNEY TUBULE; LONG TERM EXPOSURE; MALE; MESENCHYME CELL; MIXED MULLERIAN TUMOR; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; RISK ASSESSMENT; UTERUS CARCINOMA; UTERUS TUMOR;

ANIMALS; BODY WEIGHT; CARCINOGENICITY TESTS; CARCINOGENS; ENVIRONMENTAL POLLUTANTS; FEMALE; POLYBROMINATED BIPHENYLS; UTERINE NEOPLASMS; UTERUS;

MUS; RATTUS; ZEA MAYS;

EID: 84930327025     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623314557335     Document Type: Article

References (53)

1. Bailer A. J. Portier C. J. (1988). Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44, 417–31.
2. Bartels P. H. Garcia F. A. Trimble C. L. Kauderer J. Curtin J. Lim P. C. Hess L. M. Silverberg S. Zaino R. J. Yozwiak M. Bartels H. G. Alberts D. S. (2012). Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study. Gynecol Oncol 125, 129–35.
3. Birnbaum L. S. Staskal D. F. (2004). Brominated flame retardants: Cause for concern? Environ Health Perspect 112, 9–17.
4. Blom M. J. Wassink M. G. Kloosterboer H. J. Ederveen A. G. Lambert J. G. Goos H. J. (2001). Metabolism of estradiol, ethynylestradiol, and moxestrol in rat uterus, vagina, and aorta: Influence of sex steroid treatment. Drug Metab Dispos 29, 76–81.
5. Boorman G. A. Eustis S. L. (1986). The pathology working group as a means for assuring pathology quality in toxicologic studies. In Managing Conduct and Data Quality of Toxicologic Studies (Whitmire C. Davis C. L. Bristol D. W., eds.), pp. 271–75. Princeton Scientific Publishing, Princeton, NJ.
6. Bucher J. R. Morgan D. L. Adkins B. Jr Travlos G. S. Davis B. J. Morris R. Elwell M. R. (1995). Early changes in sex hormones are not evident in mice exposed to the uterine carcinogens chloroethane or bromoethane. Toxicol Appl Pharmacol 130, 169–73.
7. Burka L. T. Sanders J. M. Matthews H. B. (1996). Comparative metabolism and disposition of ethoxyquin in rat and mouse. II. Metabolism. Xenobiotica 26, 597–611.
8. Cavalieri E. Rogan E. (2014). The molecular etiology and prevention of estrogen-initiated cancers: Ockham’s Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Mol Aspects Med 36C, 1–55.
9. Center for Disease Control. (2012). National Health and Nutrition Examination Survey 199-2012 Survey Content Brochure. Accessed October 16, 2014. http://www.cdc.gov/nchs/nhanes.htm.
10. Chignell C. F. Han S. K. Mouithys-Mickalad A. Sik R. H. Stadler K. Kadiiska M. B. (2008). EPR studies of in vivo radical production by 3,3′,5,5′-tetrabromobisphenol A (TBBPA) in the Sprague-Dawley rat. Toxicol Appl Pharmacol 230, 17–22.
11. Cox D. R. (1972). Regression models and life-tables. J R Stat Soc B34, 187–220.
12. Dunnick J. K. Heath J. E. Farnell D. R. Prejean J. D. Haseman J. K. Elwell M. R. (1997). Carcinogenic activity of the flame retardant, 2,2-bis(bromomethyl)-1,3-propanediol in rodents, and comparison with the carcinogenicity of other NTP brominated chemicals. Toxicol Pathol 25, 541–48.
13. European Risk Assessment Report. (2006). European Union Risk Assessment Report: 2,2,6,6-Tetrabromo-4,4-isopropylidenediphenol (Tetrabromobisphenol-A or TBBP-A). Part II. Human Health. Office for Official Publications of the European Communities, Luxembourg. Accessed October 16, 2013. http://europa.eu/index_en.htm.
14. Gosavi R. A. Knudsen G. A. Birnbaum L. S. Pedersen L. C. (2013). Mimicking of estradiol binding by flame retardants and their metabolites: A crystallographic analysis. Environ Health Perspect 121, 1194–99.
15. Gupta N. Dudding N. Smith J. H. (2012). Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: Findings in surepath cervical cytology. Diagn Cytopathol 42, 165–69.
16. Hakk H. Larsen G. Bergman A. Orn U. (2000). Metabolism, excretion and distribution of the flame retardant tetrabromobisphenol-A in conventional and bile-duct cannulated rats. Xenobiotica 30, 881–90.
17. Hamers T. Kamstra J. H. Sonneveld E. Murk A. J. Kester M. H. Andersson P. L. Legler J. Brouwer A. (2006). In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol Sci 92, 157–73.
18. Hardisty J. G. Boorman G. A. (1986). National Toxicology Program pathology quality assurrance procedures. In Managing Conduct and Data Quality of Toxicologic Studies (Whitmire C. Davis C. L. Bristol D. W., eds.), pp. 263–69. Princeton Publishing Company, Princeton, NJ.
19. Huang G. Y. Ying G. G. Liang Y. Q. Zhao J. L. Yang B. Liu S. Liu Y. S. (2013). Hormonal effects of tetrabromobisphenol A using a combination of in vitro and in vivo assays. Comp Biochem Physiol C Toxicol Pharmacol 157, 344–51.
20. International Agency for Research on Cancer. (2012). IARC Mongraphs on the Evaluation of Carcinogenic Risks to Humans. Pharmaceuticals: A Review of Human Carcinogens. IARC, Lyon, France.
21. Kanthan R. Senger J. L. Diudea D. (2010). Malignant mixed Müllerian tumors of the uterus: Histopathological evaluation of cell cycle and apoptotic regulatory proteins. World J Surg Oncol 8, 60.
22. Karageorgi S. McGrath M. Lee I. M. Buring J. Kraft P. De Vivo I. (2011). Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk. Gynecol Oncol 121, 54–58.
23. Kaspareit-Rittinghausen J. Deerberg F. (1990). Spontaneous malignant mixed Müllerian tumors and rhabdomyosarcoma of the uterus in rats. Toxicol Pathol 18, 417–22.
24. Kitamura S. Suzuki T. Sanoh S. Kohta R. Jinno N. Sugihara K. Yoshihara S. Fujimoto N. Watanabe H. Ohta S. (2005). Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol Sci 84, 249–59.
25. Knudsen G. A. Sanders J. M. Sadik A. M. Birnbaum L. S. (2014). Disposition and kinetics of tetrabromobisphenol A in female Wistar Han rats. Toxicol Rep 1, 214–23.
26. Koenig H. Goldstone A. Blume G. Lu C. Y. (1980). Testosterone-mediated sexual dimorphism of mitochondria and lysosomes in mouse kidney proximal tubules. Science 209, 1023–26.
27. Kregel K. C. Zhang H. J. (2007). An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 292, R18–36.
28. Kuester R. K. Solyom A. M. Rodriguez V. P. Sipes I. G. (2007). The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats. Toxicol Sci 96, 237–45.
29. Kurman R. J. Kaminski P. F. Norris H. J. (1985). The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 56, 403–12.
30. Law R. J. Bersuder P. Allchin C. R. Barry J. (2006). Levels of the flame retardants hexabromocyclododecane and tetrabromobisphenol A in the blubber of harbor porpoises (Phocoena phocoena) stranded or bycaught in the U.K., with evidence for an increase in HBCD concentrations in recent years. Environ Sci & Technol 40, 2177–83.
31. Liehr J. G. (2000). Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21, 40–54.
32. Makarovsky I. Markel G. Hoffman A. Schein O. Brosh-Nissimov T. M. Finkelstien A. Tashma Z. Dushnitsky T. Eisenkraft A. (2007). Bromine—The red cloud approaching. Isr Med Assoc J 9, 677–79.
33. McCluggage W. G. (2002). Malignant biphasic uterine tumours: Carcinosarcomas or metaplastic carcinomas? J Clin Pathol 55, 321–25.
34. NIH Molecular Libraries Screening Center Network. (2014). BioAssay: AID 893 qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. Accessed October 16, 2014. http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6618.
35. National Toxicology Program. (2014). Toxicology studies of teterabromobisphenol A (CAS No. 79-94-7) in F344/NTac rats and B6C3F1/N mice and toxicology and carcinogeogenesis studies of tetrabromobisphenol A in Wistar Han [Crl:WI(Han)] rats and B6C3F1/N mice. NTP Technical Report 587. Accessed October 16, 2014. http://ntp.niehs.nih.gov/results/pubs/longterm/reports/longterm/index.html.
36. Piegorsch W. W. Bailer A. J. (1997). Statistics for Environmental Biology and Toxicology. In (Hall C. A. ed.), Vol. Section 6.3.2. Chapman and Hall, London, UK.
37. Portier C. J. Bailer A. J. (1989). Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam Appl Toxicol 12, 731–37.
38. Raftogianis R. Creveling C. Weinshilboum R. Weisz J. (2000). Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 27, 113–24.
39. Rahman F. Langford K. H. Scrimshaw M. D. Lester J. N. (2001). Polybrominated diphenyl ether (PBDE) flame retardants. Sci Total Environ 275, 1–17.
40. Rizner T. L. (2013). Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer. Mol Cell Endocrinol 381, 124–39.
41. Salmon A. B. Richardson A. Perez V. I. (2010). Update on the oxidative stress theory of aging: Does oxidative stress play a role in aging or healthy aging? Free Radic Biol Med 48, 642–55.
42. Samuelsen M. Olsen C. Holme J. A. Meussen-Elholm E. Bergmann A. Hongslo J. K. (2001). Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line. Cell Biol Toxicol 17, 139–51.
43. Schauer U. M. Völkel W. Dekant W. (2006). Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration. Toxicol Sci 91, 49–58.
44. Siegel R. Naishadham D. Jemal A. (2013). Cancer statistics, 2013. CA Cancer J Clin 63, 11–30.
45. Silverberg S. G. (2000). Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 13, 309–27.
46. Tarone R. E. (1975). Tests for trend in life table analysis. Biometrika 62, 679–82.
47. Uhnakova B. Ludwig R. Peknicova J. Homolka L. Lisa L. Sulc M. Petrickova A. Elzeinova F. Pelantova H. Monti D. Kren V. Haltrich D. Martinkova L. (2011). Biodegradation of tetrabromobisphenol A by oxidases in basidiomycetous fungi and estrogenic activity of the biotransformation products. Bioresour Technol 102, 9409–15.
48. U.S. Environmental Protection Agency. (2014). Flame retardants in printed circuit boards. Accessed October 16, 2014. http://www.epa.gov/dfe/pubs/index.htm.
49. van den Brink-Knol H. van Esch E. (2010). Spontaneous malignant mixed Müllerian tumor in a Wistar rat: A case report including immunohistochemistry. Vet Pathol 47, 1105–10.
50. Van der Ven L. T. Van de Kuil T. Verhoef A. Verwer C. M. Lilienthal H. Leonards P. E. Schauer U. M. Canton R. F. Litens S. De Jong F. H. Visser T. J. Dekant W. Stern N. Hakansson H. Slob W. Van den Berg M. Vos J. G. Piersma A. H. (2008). Endocrine effects of tetrabromobisphenol-A (TBBPA) in Wistar rats as tested in a one-generation reproduction study and a subacute toxicity study. Toxicology 245, 76–89.
51. van der Zee M. Jia Y. Wang Y. Heijmans-Antonissen C. Ewing P. C. Franken P. DeMayo F. J. Lydon J. P. Burger C. W. Fodde R. Blok L. J. (2013). Alterations in Wnt-beta-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression. J Pathol 230, 48–58.
52. Voutsadakis I. A. (2012). Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: The role of ubiquitin proteasome system and therapeutic opportunities. Clin Transl Oncol 14, 243–53.
53. Zalko D. Prouillac C. Riu A. Perdu E. Dolo L. Jouanin I. Canlet C. Debrauwer L. Cravedi J. P. (2006). Biotransformation of the flame retardant tetrabromo-bisphenol A by human and rat sub-cellular liver fractions. Chemosphere 64, 318–27.